Innovations Transforming the Global Healthcare IT, Biomarker, Biologics, and Small Molecule Landscape

Innovations Transforming the Global Healthcare IT, Biomarker, Biologics, and Small Molecule Landscape

RELEASE DATE
18-Oct-2019
REGION
Global
Research Code: D759-00-0D-00-00
SKU: HC03231-GL-TA_23708

$950.00

Special Price $712.50 save 25 %

In stock
SKU
HC03231-GL-TA_23708

$950.00

$712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) provides technological insights across 26 global healthcare innovations. The technologies analyzed include advances in digital health, biologics, small molecules, medical imaging, dental caries and precision oncology platforms. The TOE also covers application and megatrends impact, apart from exclusive analyst insights for each innovation.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Capsule Technologies, Health-IT, data management, GenXComm, Dell Technologies, digital pathology, BlueBee, Multiomics, Numares Health, precision oncology, Entasis Therapeutics Holdings Inc., Antibiotic Resistance, CALCiViS Ltd., dental caries, non-invasive diagnostics, Congenica Ltd., Genomics, Previvo Genetics LLC, non-invasive reproductive technology, Gedea Biotech AB, infectious diseases, pHyph, drug resistance, LabGenius Ltd., protein therapeutics, machine learning, Nanoform Finland Oy, drug solubility, OSSIO Inc., orthopedic surgery, bone healing, Protalix Biotherapeutics Inc., protein production, Novo Nordisk, oral glucagon-like peptide-1 (GLP-1) receptor agonist, Locus Biosciences, CRSIPR, Phage, NanoString Technologies, Inc., organ transplantation, bioMérieux, renal care, cardiac surgery, ReNeuron, stem cell therapy, Stealth BioTherapeutics, mitochondrial disease, Elamipretide, Akcea Therapeutics, liver protein, Boston Pharmaceuticals, triple-negative breast cancer, Arcellx, adaptive immune therapies, Reata Pharmaceuticals, small molecule, Friedrich’s Ataxia, Stanford University, neuron regeneration, Ziopharm Oncology, gene therapy

Table of Contents

Recent Advances in Digital Health, Multiomics and Therapy Platforms

  • Capsule Technologies
  • Capsule Technologies
  • GenXComm
  • GenXComm
  • Dell Technologies
  • Dell Technologies
  • BlueBee
  • BlueBee
  • Numares Health
  • Numares Health
  • Entasis Therapeutics Holdings Inc.
  • Entasis Therapeutics Holdings Inc.
  • CALCiViS Ltd.
  • CALCiViS Ltd.
  • Congenica Ltd.
  • Congenica Ltd.
  • Previvo Genetics LLC
  • Previvo Genetics LLC
  • Gedea Biotech AB
  • Gedea Biotech AB
  • LabGenius Ltd.
  • LabGenius Ltd.
  • Nanoform Finland Oy
  • Nanoform Finland Oy
  • OSSIO Inc.
  • OSSIO Inc.
  • Protalix Biotherapeutics Inc.
  • Protalix Biotherapeutics Inc.
  • Novo Nordisk
  • Novo Nordisk
  • Locus Biosciences
  • Locus Biosciences
  • NanoString Technologies, Inc.
  • NanoString Technologies, Inc.
  • bioMérieux
  • bioMérieux
  • ReNeuron
  • ReNeuron
  • Stealth BioTherapeutics
  • Stealth BioTherapeutics
  • Akcea Therapeutics
  • Akcea Therapeutics
  • Boston Pharmaceuticals
  • Boston Pharmaceuticals
  • Arcellx
  • Arcellx
  • Reata Pharmaceuticals
  • Reata Pharmaceuticals
  • Stanford University
  • Stanford University
  • Ziopharm Oncology
  • Ziopharm Oncology

Appendix

  • Key Contacts
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Your F&S Thought Leader
Related Research
This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) provides technological insights across 26 global healthcare innovations. The technologies analyzed include advances in digital health, biologics, small molecules, medical imaging, dental caries and precision oncology platforms. The TOE also covers application and megatrends impact, apart from exclusive analyst insights for each innovation. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Capsule Technologies, Health-IT, data management, GenXComm, Dell Technologies, digital pathology, BlueBee, Multiomics, Numares Health, precision oncology, Entasis Therapeutics Holdings Inc., Antibiotic Resistance, CALCiViS Ltd., dental caries, non-invasive diagnostics, Congenica Ltd., Genomics, Previvo Genetics LLC, non-invasive reproductive technology, Gedea Biotech AB, infectious diseases, pHyph, drug resistance, LabGenius Ltd., protein therapeutics, machine learning, Nanoform Finland Oy, drug solubility, OSSIO Inc., orthopedic surgery, bone healing, Protalix Biotherapeutics Inc., protein production, Novo Nordisk, oral glucagon-like peptide-1 (GLP-1) receptor agonist, Locus Biosciences, CRSIPR, Phage, NanoString Technologies, Inc., organ transplantation, bioMérieux, renal care, cardiac surgery, ReNeuron, stem cell therapy, Stealth BioTherapeutics, mitochondrial disease, Elamipretide, Akcea Therapeutics, liver protein, Boston Pharmaceuticals, triple-negative breast cancer, Arcellx, adaptive immune therapies, Reata Pharmaceuticals, small molecule, Friedrich’s Ataxia, Stanford University, neuron regeneration, Ziopharm Oncology, gene therapy
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-0D-00-00
Is Prebook No
Ti Codes D759